PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of ADI's 4.64%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.22%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-0.70%
Negative EBIT growth while ADI is at 13.01%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.65%
Negative operating income growth while ADI is at 13.01%. Joel Greenblatt would press for urgent turnaround measures.
0.17%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
1.21%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
0.82%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.75%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.09%
Dividend reduction while ADI stands at 0.14%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
56.45%
OCF growth above 1.5x ADI's 2.13%. David Dodd would confirm a clear edge in underlying cash generation.
68.74%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
91.35%
10Y revenue/share CAGR at 50-75% of ADI's 162.83%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
37.79%
5Y revenue/share CAGR at 50-75% of ADI's 54.09%. Martin Whitman would worry about a lagging mid-term growth trajectory.
42.33%
3Y revenue/share CAGR at 75-90% of ADI's 50.17%. Bill Ackman would expect new product strategies to close the gap.
184.81%
10Y OCF/share CAGR under 50% of ADI's 423.09%. Michael Burry would worry about a persistent underperformance in cash creation.
73.82%
Below 50% of ADI's 343.37%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
42.20%
3Y OCF/share CAGR at 50-75% of ADI's 61.42%. Martin Whitman would suspect weaker recent execution or product competitiveness.
262.30%
Net income/share CAGR above 1.5x ADI's 154.67% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
93.27%
Below 50% of ADI's 672.13%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
64.93%
3Y net income/share CAGR 1.25-1.5x ADI's 47.73%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
57.46%
Below 50% of ADI's 424.99%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.87%
Below 50% of ADI's 162.32%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
65.35%
3Y equity/share CAGR at 50-75% of ADI's 122.11%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
570.52%
10Y dividend/share CAGR above 1.5x ADI's 154.10%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.76%
5Y dividend/share CAGR above 1.5x ADI's 68.37%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.28%
3Y dividend/share CAGR 1.25-1.5x ADI's 40.76%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-6.85%
Firm’s AR is declining while ADI shows 8.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.32%
Inventory growth well above ADI's 11.91%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.40%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.73%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
9.57%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
4.11%
R&D growth drastically higher vs. ADI's 2.28%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.13%
SG&A declining or stable vs. ADI's 6.34%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.